Delhi air pollution is prompting a harder question for India’s cancer researchers: whether long-term exposure to fine particulate matter and ground-level ozone may be contributing to gastrointestinal disease and cancer risk. The question remains unresolved, but experts at a recent international conference in New Delhi said the evidence is strong enough to justify India-specific investigation.
The distinction between a warning signal and proof is central. Research cited at the conference has found associations between exposure to air pollutants and cancer outcomes, but it has not established that pollution directly causes gastrointestinal cancers or explains why some patients are being diagnosed at younger ages. Doctors also identified family history, genetic susceptibility, diet, lifestyle, infections and other environmental exposures as factors that require examination.
That makes the issue larger than a debate over one pollutant or one hospital’s patient profile. It places air quality within the wider urban health system, where exposure is widespread, health effects may take years to emerge and responsibility is divided between pollution-control agencies, municipal authorities, public-health institutions and hospitals. The evidence presented so far points to a research and governance gap: Indian cities need better information about how local pollution patterns interact with disease, but the available findings do not yet provide a direct causal explanation.
The issue was discussed during a two-day international conference on colorectal and other gastrointestinal cancers organised by Sir Ganga Ram Hospital in collaboration with the United Kingdom’s The Christie NHS Foundation Trust. The conference was held on October 10 and 11 in New Delhi and brought together specialists in medical oncology, surgical oncology and related disciplines.
Dr Shyam Aggarwal, chairperson of medical oncology at Sir Ganga Ram Hospital and the conference’s organising chairperson, said the hospital’s outpatient department was seeing new GI cancer patients as young as 15, a pattern he described as uncommon five years ago. He argued that cancer prevention could no longer be discussed only through tobacco, diet and lifestyle, and that attention also needed to be paid to the environment in which people live.
The reported hospital observation is important, but it is not the same as a population-wide trend. The supplied evidence does not establish how many younger patients were seen, whether the number represents a statistically significant increase, or whether the patient profile is representative of Delhi or India. Without those details, the observation can justify investigation but cannot independently demonstrate that early-onset GI cancers are rising because of air pollution.
The research cited at the conference provides a broader basis for concern. A study published in Epidemiologic Reviews this year examined 70 studies on air pollution and gastrointestinal diseases. It found that long-term exposure to PM2.5 was associated with higher mortality from GI cancers, particularly colorectal cancer. The finding describes an association across the studies reviewed; it does not establish that PM2.5 directly caused the cancers or deaths recorded in them.
Another study published in Nature Health this year examined the cancer burden associated with ambient air pollution across 952 locations between 2000 and 2020. It reported associations between increased exposure to PM2.5, nitrogen dioxide and ozone and higher overall cancer risk. The study was not specific to gastrointestinal cancers, and the experts cited at the conference stressed that it did not establish direct causation.
These limits matter because air pollution is not a single exposure. PM2.5 consists of fine particles that can penetrate deep into the respiratory system, while nitrogen dioxide and ozone are gaseous pollutants with different sources and behaviour. Ground-level ozone is also distinct from the protective ozone layer in the upper atmosphere. It forms when nitrogen oxides and volatile organic compounds react in sunlight, and its levels can rise during warm, sunny conditions.
Public discussion of urban air quality often focuses on PM2.5 and PM10, particularly during severe pollution episodes. The conference highlighted the need to pay closer attention to ozone as well. That does not mean ozone has been shown to cause GI cancer in Delhi. It means that pollutant monitoring and health research need to account for more than the pollutants that receive the greatest public attention.
The urban policy challenge is therefore partly one of measurement. If pollution exposure varies by season, location, occupation, mobility patterns and time spent indoors or outdoors, broad city-level air-quality readings may not capture the exposure experienced by individual residents. The supplied material does not provide a detailed exposure model for Delhi, but the experts’ call for year-round ozone monitoring indicates that short-term or narrow monitoring may not be sufficient to understand long-term health risks.
It also raises a question about how environmental health evidence is translated into public policy. Pollution-control authorities can measure and regulate emissions, while health institutions diagnose and treat disease. Research institutions must connect the two by studying exposure and outcomes over time. The conference’s emphasis on collaboration between Sir Ganga Ram Hospital and The Christie NHS Foundation Trust reflects the role of multidisciplinary and international partnerships, but it does not replace the need for evidence generated in Indian cities and among Indian populations.
Dr Saumitra Rawat, chairman of surgical gastroenterology, GI and HPB onco-surgery and liver transplantation at Sir Ganga Ram Hospital, said the diagnosis of GI cancer in younger patients warranted comprehensive investigation. He listed family history, genetic susceptibility, diet, lifestyle, infections and possible environmental exposures as factors requiring appropriate consideration. His warning against drawing conclusions from associations alone is significant: identifying a plausible environmental risk does not eliminate the need to examine other explanations.
The available data also shows why comparisons must be handled carefully. A perspective by Aggarwal on birth-cohort trends in England and India noted that early-onset colorectal cancer incidence in England rose from 3.9 per one lakh in 2001 to 8.4 per one lakh in 2023 among people under 50. India’s rate was reported as comparatively lower at 3.5 per one lakh among those aged 25 to 49, although urban cancer registries indicate an increase in colorectal cancer.
Those figures do not provide a direct comparison between Delhi’s pollution exposure and cancer incidence. They do, however, establish two relevant points. First, early-onset colorectal cancer is being examined as a changing health pattern in more than one country. Second, India’s overall reported rate and the evidence from urban registries cannot automatically be treated as contradictory. National or age-group figures may conceal differences between cities, regions, healthcare access and the populations captured by registries.
The institutional question is what kind of evidence India needs next. The experts called for India-specific research into the possible contribution of air pollutants, particularly in cities with persistently poor air quality. Such research would need to distinguish among pollutants, examine long-term exposure and account for established risk factors rather than treating air pollution as a single explanation.
The conference also linked research with diagnosis and care. Dr D S Rana, chairman of the Trust Society at Sir Ganga Ram Hospital, said coordinated work across institutions and specialities could advance cancer research, early diagnosis and patient outcomes. Selvasekar Chelliah, a consultant colorectal and laparoscopic surgeon at The Christie NHS Foundation Trust, said international collaboration could support multidisciplinary decision-making and further research into prevention, early diagnosis and environmental factors affecting long-term health.
For cities, this is a reminder that air pollution is not only an environmental compliance issue. It is also a question of health surveillance, data quality and access to timely care. Dr Rawat stressed the importance of recognising persistent digestive symptoms, seeking medical advice and ensuring access to multidisciplinary cancer care. The supplied material does not specify a screening protocol or a city-wide early-detection programme, so the practical implications remain at the level of clinical awareness and research priorities.
What the evidence confirms is limited but consequential. Long-term exposure to PM2.5 has been associated with higher mortality from GI cancers in a review of 70 studies. Broader research across 952 locations has associated PM2.5, nitrogen dioxide and ozone exposure with higher overall cancer risk. Delhi doctors are reporting concern about younger GI cancer patients and are calling for further investigation. None of these points, individually or together, proves that air pollution is causing GI cancers in Delhi.
The next step is therefore not to convert a research signal into a settled explanation. It is to build the Indian evidence base needed to test that signal against genetic, lifestyle, dietary, infectious and other environmental factors. For a city facing persistent air-quality pressure, the unanswered question is no longer whether pollution deserves health research attention. It is how quickly institutions can produce reliable, locally relevant evidence without overstating what current studies show.
